Northstar Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
AMLo Biosciencesamlo-biosciences.com𝕏May 2022 · $2M
AMLo Biosciences develops prognostic and companion diagnostic tests for cancer patients, initially focusing on melanoma and oropharyngeal squamous cell carcinoma.
BiotechDigital HealthMedical DevicesNewcastle upon Tyne, GB
Penny Lovat(Chief Scientific Officer)in
Co-investorsConduit ConnectFuture Planet CapitalMilltrust International Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.